Cross-talk between glycosylation pathways: Mechanistic insights and implications for human diseases
Molecular Metabolism · 2026
DOI: 10.1016/j.molmet.2026.102400 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Metabolism, 2026. Verfasst von Ninon Very und 1 weiteren Autor:innen. Beteiligte Einrichtung: Université de Lille, CNRS, UMR8576 UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, F-59000, Lille, France. Electronic address: ninon.very…. Hauptthemen laut MEDLINE: Glycosylation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 249 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Université de Lille, La Ligue Contre Le Cancer, Region Hauts-de-France.
Abstract (Originalsprache)
Glycosylation encompasses a broad spectrum of post-translational modifications (PTMs) that shape protein stability, spatial organization, and function. Traditionally, it is classified into two major categories: complex glycosylation within the secretory pathway - including N-glycosylation, mucin-type O-glycosylation, glycosaminoglycans (GAGs), and glycolipids - which generate structurally stable and long-lived modifications; and O-GlcNAcylation, a highly dynamic modification of nucleocytoplasmic and mitochondrial proteins that rapidly responds to metabolic and environmental cues. While this dichotomous framework has guided our understanding of glycan biology, emerging evidence now reveals that glycosylations are functionally interconnected through shared metabolic substrates, and regulatory circuits. Here, we revisit this classical classification and integrate it into a modern, systems-level view of glycosylation. We highlight the nucleotide sugar UDP-N-acetylglucosamine (UDP-GlcNAc) as a metabolic node reflecting cellular nutrient status and fuelling both complex glycan synthesis and O-GlcNAcylation. UDP-GlcNAc pool fluctuations drive coordinated remodeling across glycosylation pathways, and dysregulation of this hub is associated with diverse human diseases. We discuss how O-GlcNAcylation functions as a supplementary regulatory PTM, modulating glycosylation-related enzymes and proteins through both direct effects on their interactions, stability, localisation and activity, and via broader transcriptional and epigenetic programs, thereby dynamically controlling otherwise stable glycosylation processes. Examples from metabolic, cardiovascular, neurological diseases, cancer and congenital disorders of glycosylation (CDGs) illustrate how perturbations in one glycosylation pathway propagate through the glycosylation network, reshaping cellular identity and disease trajectories. We support a paradigm in which glycosylation operates as an integrated regulatory framework linking metabolism, signaling, and extracellular architecture, providing new perspectives for disease stratification and therapeutic intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Université de Lille, CNRS, UMR8576 UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, F-59000, Lille, France. Electronic address: ninon.very@univ-lille.fr.
- Université de Lille, CNRS, UMR8576 UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, F-59000, Lille, France. Electronic address: ikram.el-yazidi@univ-lille.fr.
Förderung
- Université de Lille
- La Ligue Contre Le Cancer
- Region Hauts-de-France
- CNRS
Zitieren
APA
Very, N., & El Yazidi-Belkoura, I. (2026). Cross-talk between glycosylation pathways: Mechanistic insights and implications for human diseases. Molecular Metabolism. https://doi.org/10.1016/j.molmet.2026.102400
Vancouver
Very N, El Yazidi-Belkoura I. Cross-talk between glycosylation pathways: Mechanistic insights and implications for human diseases. Molecular Metabolism. 2026. doi:10.1016/j.molmet.2026.102400
BibTeX
@article{Very2026,
author = {Very, Ninon and El Yazidi-Belkoura, Ikram},
title = {Cross-talk between glycosylation pathways: Mechanistic insights and implications for human diseases},
journal = {Molecular Metabolism},
year = {2026},
doi = {10.1016/j.molmet.2026.102400}
}
EUVIMED